Re: Jampol et al.: Plasma vascular endothelial growth factor concentrations after intravitreous anti-vascular endothelial growth factor therapy for diabetic macular edema (Ophthalmology. 2018;7:1054-1063)

Affiliations

¹ Tungwah Ophthalmic Center, Tungwah Hospital of Sun Yat-sen University Dongguan, Guangzhou, People's Republic of China.
² Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, People's Republic of China. Electronic address: chenshd3@mail.sysu.edu.cn.

Comment

Shaolin Du et al. Ophthalmology. 2018 Nov.

. 2018 Nov;125(11):e81-e82.

doi: 10.1016/j.ophtha.2018.05.003.

¹ Tungwah Ophthalmic Center, Tungwah Hospital of Sun Yat-sen University Dongguan, Guangzhou, People's Republic of China.
² Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, People's Republic of China. Electronic address: chenshd3@mail.sysu.edu.cn.

No abstract available

Comment in

Reply.
Glassman AR, Duh EJ, Liu D, Jampol LM. Glassman AR, et al. Ophthalmology. 2018 Nov;125(11):e82. doi: 10.1016/j.ophtha.2018.05.004. Ophthalmology. 2018. PMID: 30318048 No abstract available.

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC; Diabetic Retinopathy Clinical Research Network. Jampol LM, et al. Ophthalmology. 2018 Jul;125(7):1054-1063. doi: 10.1016/j.ophtha.2018.01.019. Epub 2018 Mar 7. Ophthalmology. 2018. PMID: 29525602 Free PMC article. Clinical Trial.